Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial - Mcmurray, J; Laakso, M; Standl, E; Tognoni, G; Holman, R; Giles, T; Martinez, F; Thomas, L; Haffner, S; Califf, R (2011)